Tonix Pharmaceuticals Holding Corp. (TNXP)
12.45
-0.10
(-0.80%)
USD |
NASDAQ |
Aug 24, 16:00
12.43
-0.02
(-0.16%)
After-Hours: 20:00
Tonix Pharmaceuticals Profit Margin (Quarterly) : -299.4% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -299.4% |
| March 31, 2026 | -584.4% |
| December 31, 2025 | -870.3% |
| September 30, 2025 | -972.9% |
| June 30, 2025 | -1.42K% |
| March 31, 2025 | -692.8% |
| Date | Value |
|---|---|
| December 31, 2024 | -856.2% |
| September 30, 2024 | -503.6% |
| June 30, 2024 | -3.57K% |
| March 31, 2024 | -601.9% |
| December 31, 2023 | -723.0% |
| September 30, 2023 | -701.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Exelixis, Inc. | 33.73% |
| Inovio Pharmaceuticals, Inc. | -- |
| Heron Therapeutics, Inc. | -14.57% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -72.99% |
| Return on Assets | -64.96% |
| Return on Invested Capital | -72.67% |
| Gross Profit Margin (Quarterly) | 90.24% |
| Operating Margin (Quarterly) | -314.1% |
| Return on Net Operating Assets | -258.9% |